Schedule 13D ownership disclosure

NKGEN BIOTECH INC

Common Stock · CUSIP: 65488A101

Event date: 2025-05-05

Filing-level shares
63,738,042.00
Percent of class
54.3%
  • Paul Y. SongReported CIK 0001991119

    Shares: 63,738,042.00 · Class: 54.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-042042
Form type
SCHEDULE 13D
Filer
NKGen Biotech, Inc.
CIK
CIK 1845459
Filed
May 12, 2025
Reporting period
May 05, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub